Cochlear | COH - Ebitda

Stock Price
197.00
Daily Change
4.00 2.07%
Monthly
-28.60%
Yearly
-25.80%
Q1 Forecast
194.59

Cochlear reported AUD292.9M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Ansell USD 192.8M 28.7M Jun/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Cochlear AUD 292.9M 30.1M Jun/2025
CSL USD 1.96B 1.27B Jun/2025
Fisher Paykel Healthcare NZD 364M 78.5M Jun/2025
Healius AUD 74.9M 40.3M Jun/2025
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Mayne Pharma AUD 20.9M 5.2M Jun/2025
Mesoblast USD -17.78M 17.03M Jun/2025
Monash IVF AUD 30.74M 4.77M Jun/2025
Nanosonics AUD 11.36M 2.36M Dec/2024
Polynovo AUD 2.86M 1.12M Jun/2024
Ramsay Health Care AUD 1.11B 84.1M Jun/2025
Regis Healthcare AUD 122.06M 27.28M Dec/2024
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Somnomed AUD 764.45K 479.23K Jun/2023
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025